Picture of Selvita SA logo

SLV Selvita SA News Story

0.000.00%
pl flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Brief: Selvita Adopts Group Strategy For 2022-2025

March 31 (Reuters) - Selvita SA  SLV1.WA :
    * ADOPTS GROUP STRATEGY FOR 2022-2025
    * UNDER STRATEGY PLANS TO TRIPLE SALES REVENUE TO ABOUT 900
MILLION ZLOTYS MAINTAINING HIGH PROFITABILITY
    * UNDER STRATEGY PLANS TO IMPLEMENT STRATEGY VIA ORGANIC
GROWTH
AND ACQUISITIONS
    * UNDER STRATEGY PLANS TO EXPAND DRUG DISCOVERY OFFER AND
BUILD
DRUG DEVELOPMENT SEGMENT
    * UNDER STRATEGY PLANS TO SPECIALISE IN SELECTED 
THERAPEUTIC 
AREAS
    * FOR IMPLEMENTATION OF STRATEGY COMPANY PLANS TO CONTRIBUTE
TOTAL
OF ABOUT 950 MILLION ZLOTYS
    * OUT OF THIS AMOUNT ABOUT 180 MILLION ZLOTYS WILL GO TO
FINANCE
ORGANIC GROWTH, WHEREAS ABOUT 270 MILLION ZLOTYS WILL GO TO
EXPANSION OF LABORATORY INFRASTRUCTURE
    * OUT OF THIS AMOUNT ABOUT 500 MILLION ZLOTYS WILL BE
ALLOCATED
FOR ACQUISITIONS

Source text for Eikon:  ID:nEMcbrDtwa 
Further company coverage:  SLV1.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Selvita SA

See all news